These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31605579)

  • 21. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
    Lee HS; Yoon JS; Roh JK; Hwang JS
    Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty.
    Kim SW; Kim YB; Lee JE; Kim NR; Lee WK; Ku JK; Kim EJ; Jung SH; Chung WY
    Ann Pediatr Endocrinol Metab; 2017 Jun; 22(2):95-101. PubMed ID: 28690987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal follow-up to near final height of auxological changes in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog and grouped by pretreatment body mass index level.
    Park J; Hwang TH; Kim YD; Han HS
    Ann Pediatr Endocrinol Metab; 2018 Mar; 23(1):14-20. PubMed ID: 29609441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty.
    Arrigo T; De Luca F; Antoniazzi F; Galluzzi F; Segni M; Rosano M; Messina MF; Lombardo F
    Eur J Endocrinol; 2004 Apr; 150(4):533-7. PubMed ID: 15080784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Body Mass Index in Girls with Idiopathic Central Precocious Puberty under Gonadotropin-Releasing Hormone Analogue Therapy: The Spanish Registry.
    Corripio R; Soriano-Guillén L; Herrero FJ; Cañete R; Castro-Feijoó L; Escribano A; Espino R; Labarta JI; Argente J
    Horm Res Paediatr; 2016; 86(3):154-160. PubMed ID: 27529349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.
    Arcari AJ; Freire AV; Escobar ME; Ballerini MG; Ropelato MG; Bergadá I; Gryngarten MG
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):181-186. PubMed ID: 30699070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty].
    Wang CL; Liang L; Liu PN; Jin XJ; Chen LQ; Yang F; Lian Q; Chen RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):25-30. PubMed ID: 24461173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Girls with idiopathic central precocious puberty did not display substatial changes in body mass index after treatment with gonadotropin-releasing hormone analogues.
    Uldbjerg CS; Lim YH; Renault CH; Hansen D; Juul A; Bräuner EV; Jensen RB
    Acta Paediatr; 2024 Jul; 113(7):1602-1611. PubMed ID: 38506052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of GnRHa Treatment on Body Mass Index in Central Precocious Puberty: A Systematic Review and Meta-Analysis.
    Hou L; Ying Y; Wu W; Ye F; Zhang C; Luo X
    Horm Res Paediatr; 2024; 97(5):419-432. PubMed ID: 38185120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
    Liang Y; Wei H; Li J; Hou L; Zhang J; Wu W; Ying Y; Luo X
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):839-46. PubMed ID: 25719299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls.
    Shi Y; Ma Z; Yang X; Ying Y; Luo X; Hou L
    Front Endocrinol (Lausanne); 2022; 13():1085385. PubMed ID: 36589818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D; Karavani G; Hirsch HJ; Strich D
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study.
    Lin YC; Lin CY; Chee SY; Yen HR; Tsai FJ; Chen CY; Wang CH
    PLoS One; 2017; 12(10):e0185080. PubMed ID: 28973010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
    Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
    Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls.
    Fu J; Zhang J; Chen R; Ma X; Wang C; Chen L; Liang Y; Luo X; Yang Y; Xiong F; Su Z; Wu J; Yao H; Xu J; Wu D; Ni Y
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31702013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.